Contact
11.02.2023 Medeor Therapeutics Announces Interim Data from Pivotal Trial Showing Cell Therapy Technology Could Eliminate Life-Long Need for Immunosuppressant Drugs Following Kidney Transplant
10.25.2023 Medeor Therapeutics to Present Interim Pivotal Data on MDR-101 Cell Therapy for Induction of Immune Tolerance and Elimination of Immunosuppressants Following Kidney Transplant in Late Breaker Oral Presentation at ASN Kidney Week 2023
09.30.2020 Medeor Therapeutics Announces Data Presentation at the American Society of Nephrology Kidney Week 2020
09.22.2020 Medeor Therapeutics’ Transplant Immune Tolerance Therapy Receives Regenerative Medicine Advanced Therapy Designation from FDA